Lymph node density - Prognostic value in head and neck cancer

Head and Neck

Volumn 36, Issue 2, 2014, Pages 266-272

  Rudra, Sonali ^a   Spiotto, Michael T ^a   Witt, Mary Ellyn ^a   Blair, Elizabeth A ^a   Stenson, Kerstin ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

head and neck; lymph node density; prognosis; radiation; surgery

Indexed keywords

CARBOPLATIN; FLUOROURACIL; GEFITINIB; HYDROXYUREA; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DATA BASE; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE DENSITY; LYMPH NODE DISSECTION; LYMPHATIC PARAMETERS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE;

HEAD AND NECK; LYMPH NODE DENSITY; PROGNOSIS; RADIATION; SURGERY;

ADULT; AGED; CHEMORADIOTHERAPY; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84892442133     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23299     Document Type: Article

References (28)

1. Siegel R, Ward E, Brawley O, Jemal A,. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
2. Haddad RI, Shin DM,. Recent advances in head and neck cancer. N Engl J Med 2008; 359: 1143-1154.
3. Freeman DE, Mendenhall WM, Parsons JT, Million RR,. Does neck stage influence local control in squamous cell carcinomas of the head and neck? Int J Radiat Oncol Biol Phys 1992; 23: 733-736.
4. Rudoltz MS, Benammar A, Mohiuddin M,. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int J Radiat Oncol Biol Phys 1995; 31: 503-508.
5. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J,. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994; 168: 494-498.
6. Shingaki S, Takada M, Sasai K, et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 2003; 185: 278-284.
7. van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA,. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28: 481-489.
8. Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 2009; 27: 1062-1068.
9. Herr HW,. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003; 169: 943-945.
10. Siewert JR, Böttcher K, Stein HJ, Roder JD,. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461.
11. Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 2009; 13: 1337-1344.
12. Ebrahimi A, Clark JR, Zhang WJ, et al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck 2011; 33: 1245-1251.
13. Gil Z, Carlson DL, Boyle JO, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 2009; 115: 5700-5710.
14. Shrime MG, Bachar G, Lea J, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck 2009; 31: 1482-1488.
15. Kim SY, Nam SY, Choi SH, Cho KJ, Roh JL,. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol 2011; 18: 2310-2317.
16. Cohen EE, Haraf DJ, Kunnavakkam R, et al. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2010; 28: 3336-3343.
17. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19: 1961-1969.
18. Rosen FR, Haraf DJ, Kies MS, et al. Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res 2003; 9: 1689-1697.
19. Cerezo L, Millán I, Torre A, Aragõn G, Otero J,. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 1992; 69: 1224-1234.
20. Choe KS, Salama JK, Stenson KM, et al. Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. Radiother Oncol 2010; 97: 318-321.
21. Kowalski LP, Magrin J, Waksman G, et al. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch Otolaryngol Head Neck Surg 1993; 119: 958-963.
22. Swanson RS, Compton CC, Stewart AK, Bland KI,. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
23. Soo KC, Tan EH, Wee J, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005; 93: 279-286.
24. Pignon JP, le Maître A, Maillard E, Bourhis J,; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
25. Stenson KM, Kunnavakkam R, Cohen EE, et al. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 2010; 120: 93-99.
26. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J,. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 2008; 112: 535-543.
27. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952.
28. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005; 27: 843-850.